Latest News | Gufic Biosciences Gets CDSCO Nod to Market Drug for Severe Fungal Infections
Get latest articles and stories on Latest News at LatestLY. Gufic Biosciences on Monday said it has received an approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market a drug used to treat invasive Aspergillosis and Mucormycosis.
New Delhi, Apr 25 (PTI) Gufic Biosciences on Monday said it has received an approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market a drug used to treat invasive Aspergillosis and Mucormycosis.
The company has received approval for the production, sale and distribution of Isavuconazonium Sulfate API and finished formulation Isavuconazole for Injection 200 mg/vial, the company said in a statement.
Also Read | OnePlus 10R 5G, Nord CE 2 Lite 5G & Nord Buds India Prices Leaked Online: Report.
Isavuconazole for Injection 200 mg/vial is indicated for the treatment of patients who are 18 years of age and above.
"Isavuconazole is a systemic antifungal drug of triazole class. Isavuconazole is already approved by USFDA on March 6, 2015 and European Medicines Agency (EMA) on October 15, 2015," Gufic Biosciences Chief Operating Officer Nagesh Y noted.
The incidence of invasive fungal infections has been increasing over the past few decades and it represents a significant problem in immunocompromised individuals and a large proportion of critically ill patients, he added.
"Also, during the second wave of Covid-19, there has been a significant increase in number of cases of Mucormycosis in Covid-19 patients across India during treatment in hospitals and after discharge. This is where Isavuconazole has come as a boon for these patients," Nagesh Y stated.
Besides India, Gufic is expanding presence in Germany, Switzerland, South Africa, Russia, Canada, Europe and other key countries within the emerging market territories.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)